CYSTINOSIS RESEARCH FOUNDATION
Balance Sheet
Fiscal Year Start:
Jul 1
Assets in 2025 (Year End)
$10,029,960
Investments
55%
Cash & Equivalents
44%
Other Assets
<1%
Prepaid Expenses
<1%
Receivables (Non-Related)
0%
Related-Party Receivables
0%
Inventories
0%
Property, Plant, & Equipment (net)
0%
Liabilities in 2025 (Year End)
$2,507,429
Grants Payable
98%
Other Liabilities
1%
Payables & Accruals
1%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2024
2025
Change
Cash & Equivalents
$5,144,486
$4,442,951
-14%
Receivables (Non-Related)
$0
$0
-
Related-Party Receivables
$0
$0
-
Inventories
$0
$0
-
Prepaid Expenses
$48,476
$12,937
-73%
Investments
$5,140,525
$5,540,997
+8%
Property, Plant, & Equipment (net)
$17,123
$0
-100%
Other Assets
$64,774
$33,075
-49%
Total Assets
$10,415,384
$10,029,960
-4%
Liabilities
2024
2025
Change
Payables & Accruals
$31,780
$27,965
-12%
Grants Payable
$2,572,904
$2,445,953
-5%
Deferred Revenue
-
-
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
$64,609
$33,511
-48%
Total Liabilities
$2,669,293
$2,507,429
-6%
Net assets
2024
2025
Change
Restricted Net Assets
-
-
-
Unrestricted Net Assets
$7,746,091
$7,522,531
-3%
Net assets
2024
2025
Change
Net assets
+$7,746,091
+$7,522,531
-3%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)